NLM Logo

galiximab MeSH Supplementary Concept Data 2023


MeSH Supplementary
galiximab
Unique ID
C437823
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C437823
Entry Term(s)
IDEC-114
P-16C10
anti-B7-1 mAb
primatized anti-B7 antibody
Pharm Action
Anti-Inflammatory Agents
Antineoplastic Agents
Registry Number
S9OX9692ZB
Related Numbers
357613-77-5
Heading Mapped to
*Antibodies, Monoclonal
Frequency
21
Note
for the treatment of lymphoma, autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis
Source
Curr Opin Investig Drugs 2001 May;2(5):635-8
Date of Entry
2001/10/24
Revision Date
2019/10/31
galiximab Preferred
P-16C10 Narrower
anti-B7-1 mAb Narrower
IDEC-114 Narrower
page delivered in 0.006s